Healthy Clinical Trial
Official title:
VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases
This protocol will screen healthy normal volunteers for participation in studies of vaccines
under development at NIAID's Vaccine Research Center. Of interest are vaccines for:
- Newly identified infectious diseases such as SARS.
- Infectious diseases of concern as possible bioweapons, such as smallpox and Ebola virus
- Emerging infectious diseases that are more widespread geographically than in the past,
such as West Nile virus
- For preventing diseases such as tuberculosis and malaria.
Healthy normal volunteers between 18 and 70 years of age may be eligible for this protocol.
Screening begins about 1 to 6 months before the start of the vaccine study. Participants will
have a physical examination and health history, including questions about sexual activity and
drug use. Over the course of the screening visits, participants will be asked to give urine
and blood samples to test for various infections and other medical problems. Women capable of
getting pregnant will be given a pregnancy test. Women who are pregnant or breastfeeding will
not be enrolled in the study.
At the end of the screening, participants will be informed about which vaccines are currently
being tested in clinical trials for which they may be eligible. Once participants enroll in a
vaccine study, their participation in the screening protocol ends.
STUDY DESIGN: The purpose of the study is to screen potential study volunteers to determine
if they are eligible for infectious disease vaccine clinical trials being sponsored by the
Vaccine Research Center (VRC) at the NIH Clinical Center. All work will be conducted by the
VRC Clinic of the National Institutes of Health or IRB-approved extramural sites that are
collaborating with the VRC Clinic. Educational materials on vaccines will be reviewed with
and provided to subjects before enrollment into the study.
SUBJECTS: Approximately 3,000 healthy adults; age 18-70 years.
STUDY DURATION: Duration of participation is variable, and may last from a few weeks to
several months for each subject. Study participation is complete when the subject enrolls in
a vaccine study, is found to be ineligible for all vaccine studies or declines to participate
in any vaccine studies.
STUDY EVALUATIONS: Evaluations usually include history, physical examinations and laboratory
tests. Only those evaluations needed to determine eligibility for a particular study will be
done. Evaluations other than those described in this protocol may be done if necessary for
eligibility for a study. Blood will also be collected for storage.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |